Mark T. Lin
Impact in
- Immunology top 5%
- T-cell and B-cell Immunology
- interferon and immune responses
Papers in
-
- interferon and immune responses 5
- T-cell and B-cell Immunology 3
-
- Multiple Sclerosis Research Studies 4
- Co-authors
- David R. Hinton (9 shared papers)Stephen A. Stohlman (9 shared papers)Timothy E. Albertson (1 shared paper)Cornelia C. Bergmann (6 shared papers)Beatriz Parra (5 shared papers)Norman W. Marten (2 shared papers)José María Mato (2 shared papers)Shelly Chi-Loo Lu (2 shared papers)
- Journals
- The Journal of Immunology (3 papers)Nature Medicine (2 papers)Virology (2 papers)Advances in experimental medicine and biology (2 papers)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United StatesSpainCanada
In The Last Decade
Mark T. Lin
20 papers receiving 1.5k citations
Mark T. Lin's Hit Papers
Peers
Comparison fields: 5 of 75
- Immunology 345
- Critical Care and Intensive Care Medicine 74
- Oncology 289
- Neurology 86
- Animal Science and Zoology 102
Countries citing papers authored by Mark T. Lin
This map shows the geographic impact of Mark T. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark T. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark T. Lin more than expected).
Fields of papers citing papers by Mark T. Lin
This network shows the impact of papers produced by Mark T. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark T. Lin. The network helps show where Mark T. Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark T. Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation Hit paper breakdown → | 2023 | 247 |
| 2 | 1999 | 191 | |
| 3 | 2004 | 175 | |
| 4 | 1998 | 140 | |
| 5 | 2007 | 104 | |
| 6 | 2023 | 102 | |
| 7 | 2022 | 93 | |
| 8 | 1999 | 88 | |
| 9 | 2009 | 78 | |
| 10 | 1997 | 70 | |
| 11 | 2000 | 56 | |
| 12 | 1998 | 52 | |
| 13 | 2001 | 52 | |
| 14 | 2019 | 48 | |
| 15 | 2015 | 22 | |
| 16 | 2025 | 20 | |
| 17 | 2020 | 16 | |
| 18 | 1998 | 10 | |
| 19 | 1998 | 5 | |
| 20 | Immune regulation of coronavirus-induced demyelinating encephalomyelitis. | 1997 | 1 |
About Mark T. Lin
Mark T. Lin is a scholar working on Immunology, Pathology and Forensic Medicine, Virology, Biotechnology and Animal Science and Zoology, having authored 20 papers that have together received 1.6k indexed citations. Recurring topics across this work include interferon and immune responses (5 papers), Multiple Sclerosis Research Studies (4 papers), T-cell and B-cell Immunology (3 papers), Lung Cancer Treatments and Mutations (2 papers), Infectious Encephalopathies and Encephalitis (2 papers), HIV Research and Treatment (2 papers), Hepatitis B Virus Studies (2 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Immunology (345 citations), Critical Care and Intensive Care Medicine (74 citations), Oncology (289 citations), Neurology (86 citations) and Animal Science and Zoology (102 citations). Mark T. Lin has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include David R. Hinton, Stephen A. Stohlman, Timothy E. Albertson, Cornelia C. Bergmann, Beatriz Parra, Norman W. Marten, José María Mato, Shelly Chi-Loo Lu, Dennis John Kuo and Roel C. van der Veen. Their work appears in journals such as The Journal of Immunology, Nature Medicine, Virology, Advances in experimental medicine and biology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.